drugset / Trial / NCT02131194
The Post-Vitrectomy Lenstatin™ Study
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenstatin | Other / unclassified | 2 unknown | Oral |